← board
BZYR
distress 4/10 · elevated risk$0.010%today-88% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.0 yrs
Shares 1y
0%
Price & events
-84.2% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+50.0%
1W
-33.3%
1M
-81.3%
3M
-84.2%
6M
-86.7%
1Y
-85.7%
2Y
-80.6%
5Y
-66.7%
All
Overview
- Market Cap
- $788.69K
- Volume
- 0
- 52 Week Range
- $0.00 – $0.05
- Total Shares
- 131.45M
- Float Shares
- 24.97M
- % Held by Insiders
- 81.00%
- % Held by Institutions
- 0.00%
- Beta
- 0.37
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 131,448,444 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.